Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Daniel L. Van Dyke"'
Autor:
J. Erin Wiedmeier-Nutor, Chantal E. McCabe, Daniel R. O’Brien, Erik Jessen, Cecilia Bonolo de Campos, Nicholas J. Boddicker, Rosalie Griffin, Cristine Allmer, Kari G. Rabe, James R. Cerhan, Sameer A. Parikh, Neil E. Kay, Huihuang Yan, Daniel L. Van Dyke, Susan L. Slager, Esteban Braggio
Publikováno v:
Cancers, Vol 16, Iss 13, p 2450 (2024)
Chronic lymphocytic leukemia (CLL) is characterized by multiple copy number alterations (CNAs) and somatic mutations that are central to disease prognosis, risk stratification, and mechanisms of therapy resistance. Fluorescence in situ hybridization
Externí odkaz:
https://doaj.org/article/df67c463b81c49e2a220aa998415ea52
Autor:
Paul J. Hampel, Kari G. Rabe, Timothy G. Call, Wei Ding, Jose F. Leis, Asher A. Chanan-Khan, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber B. Koehler, Ricardo Parrondo, Susan M. Schwager, Taimur Sher, Curtis A. Hanson, Min Shi, Daniel L. Van Dyke, Esteban Braggio, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-6 (2022)
Abstract Patients with chronic lymphocytic leukemia (CLL) with disease progression on ibrutinib have worse outcomes compared to patients stopping ibrutinib due to toxicity. A better understanding of expected outcomes in these patients is necessary to
Externí odkaz:
https://doaj.org/article/c5ee38417b3b4e7f8218d469cd1ba54f
Autor:
Yucai Wang, Sutapa Sinha, Linda E. Wellik, Charla R. Secreto, Karen L. Rech, Timothy G. Call, Sameer A. Parikh, Saad S. Kenderian, Eli Muchtar, Suzanne R. Hayman, Amber B. Koehler, Daniel L. Van Dyke, Jose F. Leis, Susan L. Slager, Haidong Dong, Neil E. Kay, Rong He, Wei Ding
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-9 (2021)
Abstract Richter syndrome (RS) refers to transformation of chronic lymphocytic leukemia (CLL) to an aggressive lymphoma, most commonly diffuse large B-cell lymphoma. RS is known to be associated with a number of genetic alterations such as TP53 and N
Externí odkaz:
https://doaj.org/article/6b326bb24b624e97b5dc1e2dce130e5f
Autor:
Paul J. Hampel, Sameer A. Parikh, Timothy G. Call, Mithun V. Shah, N. Nora Bennani, Aref Al-Kali, Kari G. Rabe, Yucai Wang, Eli Muchtar, Jose F. Leis, Saad S. Kenderian, Amber B. Koehler, Susan M. Schwager, Susan L. Slager, Neil E. Kay, Curtis A. Hanson, Daniel L. Van Dyke, Min Shi, Wei Ding
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-6 (2021)
Externí odkaz:
https://doaj.org/article/5034355e2436472d9133161b489aabbc
Autor:
Yucai Wang, Marcella A. Tschautscher, Kari G. Rabe, Timothy G. Call, Jose F. Leis, Saad S. Kenderian, Neil E. Kay, Eli Muchtar, Daniel L. Van Dyke, Amber B. Koehler, Susan M. Schwager, Susan L. Slager, Sameer A. Parikh, Wei Ding
Publikováno v:
Haematologica, Vol 105, Iss 3 (2020)
The natural history, prognostication and optimal treatment of Richter transformation developed from chronic lymphocytic leukemia (CLL) are not well defined. We report the clinical characteristics and outcomes of a large series of biopsy-confirmed Ric
Externí odkaz:
https://doaj.org/article/0a28ead1701247398d3622a34a0b481c
Autor:
Yucai Wang, Kari G. Rabe, Michael S. Bold, Min Shi, Curtis A. Hanson, Susan M. Schwager, Timothy G. Call, Saad S. Kenderian, Eli Muchtar, Suzanne R. Hayman, Amber B. Koehler, Amie L. Fonder, Asher A. Chanan-Khan, Daniel L. Van Dyke, Susan L. Slager, Neil E. Kay, Wei Ding, Jose F. Leis, Sameer A. Parikh
Publikováno v:
Haematologica, Vol 105, Iss 11 (2020)
Externí odkaz:
https://doaj.org/article/583604c4d80b473c848de91a69758bf4
Autor:
Steven R Hwang, Yucai Wang, Kari G Rabe, Rong He, Saad S. Kenderian, Eli Muchtar, Paul J. Hampel, Neil E. Kay, Timothy G. Call, Amber Koehler, Amy L Behnken, Jose F. Leis, Esteban Braggio, Min Shi, David S. Viswanatha, Daniel L. Van Dyke, Susan L. Slager, Sameer A. Parikh, Wei Ding
Publikováno v:
Blood. 140:12390-12392
Autor:
Marie‐France Gagnon, Holly E. Berg, Reid G. Meyer, William R. Sukov, Daniel L. Van Dyke, Robert B. Jenkins, Patricia T. Greipp, Erik C. Thorland, Nicole L. Hoppman, Xinjie Xu, Linda B. Baughn, Kaaren K. Reichard, Rhett P. Ketterling, Jess F. Peterson
Publikováno v:
Genes, Chromosomes and Cancer. 61:629-634
Autor:
Xinjie Xu, Patricia T. Greipp, George Vasmatzis, Horatiu Olteanu, Patrick W. McGarrah, Daniel L. Van Dyke, Nicole L. Hoppman, Sarah H. Johnson, Rhett P. Ketterling, Jess F. Peterson, Alaa Koleilat, James B. Smadbeck, Mrinal S. Patnaik, Linda B. Baughn
Publikováno v:
Cancer Genetics. :1-5
The t(4;12)(q12;p13) has been rarely reported in both myeloid/lymphoid neoplasms with eosinophilia (ETV6/PDGFRA gene fusion) and acute myeloid leukemia (AML) (ETV6/CHIC2 gene fusion). The ability to accurately characterize t(4;12) is critical as myel
Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome
Autor:
Shulan Tian, Timothy G. Call, Charla R. Secreto, Jennifer H. Yearley, Wendy M. Blumenschein, Wei Ding, Daniel L. Van Dyke, Hanyin Wang, Sameer A. Parikh, Neil E. Kay, Huihuang Yan, Susan L. Slager, Qing Zhao, Rong He, Esteban Braggio, Jose F. Leis, Saad J. Kenderian, Min Shi, Yucai Wang, Sutapa Sinha
Publikováno v:
Blood
The transformation of chronic lymphocytic leukemia (CLL) to high-grade B-cell lymphoma is known as Richter syndrome (RS), a rare event with dismal prognosis. In this study, we conducted whole-genome sequencing (WGS) of paired circulating CLL (PB-CLL)